Second, as noted above in section 4.1.2, there are high barriers to entry in the GM
produced lactase manufacturing market. Manufacturers need to develop the required technology (lactase enzyme and GM production host), the required 186 PN RFI 1, Annex RFI1-Q55.032, slide 4. 187 Form CO. para. 1511. 188 Form CO. para. 1511. 189 PN RFI5, Annex RFI5-Q17.015, slide 16. 190 For Novozymes, see PN RFI5, Annex RFI5-Q17.031, slide 5. 191 For Chr. Hansen, see PN RFI5, Annex RFI5_Q16.008, slide 18. 192 Form CO. para. 696. 193 eRFI to competitors and distributors, question C.1. 194 Email submission sent by Linklaters on 28.11.2023. manufacturing capabilities, obtain a number of regulatory authorisations and develop market access. As a result, most responding manufacturers consider that more than 2 years are needed for a manufacturer of another food and beverage enzymes to start producing and commercially supplying GM produced lactase195 as well as an investment of less than EUR 10 million or between EUR 10 million and EUR 50 million196 depending on the existing resources of the manufacturer.197 The Commission observes that indeed, it has [information on status of G2 Project].